BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10652575)

  • 1. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas.
    Dumas V; Kanitakis J; Charvat S; Euvrard S; Faure M; Claudy A
    Anticancer Res; 1999; 19(4B):2929-38. PubMed ID: 10652575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
    Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
    J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High numbers of human skin cancers express MMP2 and several integrin genes.
    Orimoto AM; Neto CF; Pimentel ER; Sanches JA; Sotto MN; Akaishi E; Ruiz IR
    J Cutan Pathol; 2008 Mar; 35(3):285-91. PubMed ID: 18251742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
    O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
    Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of cell surface CD44 in nonmelanoma skin tumours is associated with increased expression of matrix metalloproteinase 7.
    Hartmann-Petersen S; Tammi RH; Tammi MI; Kosma VM
    Br J Dermatol; 2009 Jun; 160(6):1251-7. PubMed ID: 19222463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential protease expression by cutaneous squamous and basal cell carcinomas.
    Sappino AP; Belin D; Huarte J; Hirschel-Scholz S; Saurat JH; Vassalli JD
    J Clin Invest; 1991 Oct; 88(4):1073-9. PubMed ID: 1918364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas.
    Walter A; Barysch MJ; Behnke S; Dziunycz P; Schmid B; Ritter E; Gnjatic S; Kristiansen G; Moch H; Knuth A; Dummer R; van den Broek M
    Clin Cancer Res; 2010 Jul; 16(14):3562-70. PubMed ID: 20519358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of matrix metalloproteinase inhibitors against epidermal basement membrane damage: skin equivalents partially mimic photoageing process.
    Amano S; Ogura Y; Akutsu N; Matsunaga Y; Kadoya K; Adachi E; Nishiyama T
    Br J Dermatol; 2005 Dec; 153 Suppl 2():37-46. PubMed ID: 16280020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
    de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
    Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas.
    Ohashi K; Nemoto T; Nakamura K; Nemori R
    Cancer; 2000 May; 88(10):2201-9. PubMed ID: 10820340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice.
    Akgül B; Pfefferle R; Marcuzzi GP; Zigrino P; Krieg T; Pfister H; Mauch C
    Exp Dermatol; 2006 Jan; 15(1):35-42. PubMed ID: 16364029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
    Kivisaari AK; Kallajoki M; Mirtti T; McGrath JA; Bauer JW; Weber F; Königová R; Sawamura D; Sato-Matsumura KC; Shimizu H; Csikós M; Sinemus K; Beckert W; Kähäri VM
    Br J Dermatol; 2008 Apr; 158(4):778-85. PubMed ID: 18284387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients.
    Kuivanen T; Jeskanen L; Kyllönen L; Isaka K; Saarialho-Kere U
    J Cutan Pathol; 2009 Sep; 36(9):929-36. PubMed ID: 19674198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invading squamous cell carcinoma can retain a basal lamina. An immunohistochemical study using a monoclonal antibody to type IV collagen.
    Gusterson BA; Warburton MJ; Mitchell D; Kraft N; Hancock WW
    Lab Invest; 1984 Jul; 51(1):82-7. PubMed ID: 6737996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas.
    Théret N; Musso O; Turlin B; Lotrian D; Bioulac-Sage P; Campion JP; Boudjéma K; Clément B
    Hepatology; 2001 Jul; 34(1):82-8. PubMed ID: 11431737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of balance between extracellular matrix synthesis and degradation in basement membrane formation.
    Amano S; Akutsu N; Matsunaga Y; Nishiyama T; Champliaud MF; Burgeson RE; Adachi E
    Exp Cell Res; 2001 Dec; 271(2):249-62. PubMed ID: 11716537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.
    Kerkelä E; Ala-aho R; Lohi J; Grénman R; M-Kähäri V; Saarialho-Kere U
    Br J Cancer; 2001 Mar; 84(5):659-69. PubMed ID: 11237387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
    Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS
    J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.
    Parmo-Cabañas M; Molina-Ortiz I; Matías-Román S; García-Bernal D; Carvajal-Vergara X; Valle I; Pandiella A; Arroyo AG; Teixidó J
    J Pathol; 2006 Jan; 208(1):108-18. PubMed ID: 16278822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
    Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.